Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Beals, US
Brian S. Beals, Grand Rapids, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20110303589 | GRAVITY FEED WATER TREATMENT SYSTEM - A portable water treatment system includes at least one sub-system to treat water including a flocculation system, a chlorination system, and a bio-sand filter system. The water treatment system may include multiple sub-systems for treating water that feed into one another. The sand filter system may include a mini bio-sand filter, a foam filter, or a pressed block filter. The flocculation system may include a tank bottom that urges settling particles toward a sump and a ladle that removes settled particles. A manual pump or siphon may be included in the water treatment system. | 12-15-2011 |
Channing R. Beals, Westfield, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100267751 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING DRY EYE DISORDERS - Inhibitors of Janus kinase-3 (“Jak3”) are useful for treating dry eye disorders and other disorders requiring the wetting of the eye. Jak3 inhibitors useful for treating eye disorders include the compound 3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo [2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile. | 10-21-2010 |
John Michael Beals, Indianapolis, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20090118190 | MUTEINS OF FIBROBLAST GROWTH FACTOR 21 - The present invention relates to novel muteins of human fibroblast growth factor 21 with improved pharmaceutical properties. Both protein and the respective encoding nucleic acid species are disclosed. The invention also embodies vectors and host cells for the propagation of said nucleic acid sequences and the production of said muteins. Also disclosed are methods for treating type 2 diabetes, obesity, metabolic syndrome, and in reducing the mortality and morbidity of critically ill patients. | 05-07-2009 |
| 20090312236 | PEGYLATED INSULIN LISPRO COMPOUNDS - The present invention relates to the field of diabetes. More particularly, the invention relates to PEGylated insulin lispro compounds that are PEGylated with high molecular weight poly(ethylene glycol), are highly soluble at physiological pH, have an extended duration of action, and characterized by pharmacokinetic, pharmacodynamic, and/or activity peak-trough ratios of less than 2. The invention also relates to methods of providing such molecules, to pharmaceutical compositions containing them, and to their therapeutic uses. | 12-17-2009 |
| 20110105392 | Pegylated Insulin Lispro Compounds - The present invention relates to the field of diabetes. More particularly, the invention relates to PEGylated insulin lispro compounds that are PEGylated with high molecular weight poly(ethylene glycol), are highly soluble at physiological pH, have an extended duration of action, and characterized by pharmacokinetic, pharmacodynamic, and/or activity peak-trough ratios of less than 2. The invention also relates to methods of providing such molecules, to pharmaceutical compositions containing them, and to their therapeutic uses. | 05-05-2011 |
Joseph Beals, Corte Madera, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090198610 | Credit Risk Prediction And Bank Card Customer Management By Integrating Disparate Data Sources - A future behavior prediction system includes a scoring engine to generate a final prediction score for a credit account holder from a combination of two or more variable summaries. Each variable summary is a summary of variable data from one of a number of data sources. The number of data sources include at least a master billing data source and an authorization transaction data source. | 08-06-2009 |
Joseph Beals, Marshfield, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110176764 | INTEGRATED PLANAR POLYMER WAVEGUIDE FOR LOW-LOSS, LOW-CROSSTALK OPTICAL SIGNAL ROUTING - The present invention provides a planar waveguide. In one embodiment, the planar waveguide includes first and third layers formed above a substrate and adjacent each other. The first and third layers are formed of a first material having a first index of refraction. The planar waveguide also includes a second layer formed between the first and third layers of a second material having a second index of refraction that is larger than the first index of refraction. The planar waveguide further includes a plurality of organo-functional siloxane based resin or polymer waveguides formed in the second layer. Each organo-functional siloxane based resin or polymer waveguide has an input on one edge of the second layer and an output on one edge of the second layer so that the input and output are on different line-of-sight paths. The plurality of organo-functional siloxane based resin or polymer waveguides is formed such that intersections of the plurality of organo-functional siloxane based resin or polymer waveguides occur at approximately right angles. | 07-21-2011 |
Neil Beals, Memphis, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20100086600 | Flowable Carrier Matrix - A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These pieces are sized so that, when wet, they are capable of flowing through a cannula and/or reduced-diameter syringe tip. The pieces are placed into a syringe and wetted, say with a morphogenic solution, and optionally mixed with a bulking material, which is similarly sized to fit through the cannula. The thoroughly mixed and wetted product forms a viscous aggregate which may then be injected into the patient at the target site. | 04-08-2010 |
| 20100112069 | Flowable Carrier Matrix - A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These pieces are sized so that, when wet, they are capable of flowing through a cannula and/or reduced-diameter syringe tip. The pieces are placed into a syringe and wetted, say with a morphogenic solution, and optionally mixed with a bulking material, which is similarly sized to fit through the cannula. The thoroughly mixed and wetted product forms a viscous aggregate which may then be injected into the patient at the target site. | 05-06-2010 |
| 20100266658 | Osteogenic Implants with Combined Implant Materials and Methods for Same - Described are osteogenic implants that include a first implant material covered at least in part by a second implant material carrying an osteogenic protein such as a bone morphogenic protein. The first implant material can comprise a mineral and provide an inner scaffolding portion for supporting bone ingrowth, and the second implant material can comprise a collagen or other sponge carrier covering the first implant material and having a liquid osteogenic protein formulation imbibed therein. Related implant materials and methods of preparation and use constitute additional aspects of the invention. | 10-21-2010 |
| 20100266660 | Osteogenic Implants with Combined Implant Materials and Methods for Same - Described are osteogenic implants that include a first implant material covered at least in part by a second implant material carrying an osteogenic protein such as a bone morphogenic protein. The first implant material can comprise a mineral and provide an inner scaffolding portion for supporting bone ingrowth, and the second implant material can comprise a collagen or other sponge carrier covering the first implant material and having a liquid osteogenic protein formulation imbibed therein. Related implant materials and methods of preparation and use constitute additional aspects of the invention. | 10-21-2010 |
| 20110092953 | Flowable Carrier Matrix - A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These pieces are sized so that, when wet, they are capable of flowing through a cannula and/or reduced-diameter syringe tip. The pieces are placed into a syringe and wetted, say with a morphogenic solution, and optionally mixed with a bulking material, which is similarly sized to fit through the cannula. The thoroughly mixed and wetted product forms a viscous aggregate which may then be injected into the patient at the target site. | 04-21-2011 |
Neil B. Beals, Memphis, TN US
| Patent application number | Description | Published |
|---|---|---|
| 20100266661 | OSTEOGENIC IMPLANTS WITH COMBINED IMPLANT MATERIALS AND METHODS FOR SAME - Described are osteogenic implants that include a first implant material covered at least in part by a second implant material carrying an osteogenic protein such as a bone morphogenic protein. The first implant material can comprise a mineral and provide an inner scaffolding portion for supporting bone ingrowth, and the second implant material can comprise a collagen or other sponge carrier covering the first implant material and having a liquid osteogenic protein formulation imbibed therein. Related implant materials and methods of preparation and use constitute additional aspects of the invention. | 10-21-2010 |
Peyton C. Beals, Wrentham, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20080236243 | Pressure Monitor Optimization of Fluid Path Utilization - A device comprising a pressure monitor and a control means that receives a signal representing measured pressure at the pressure monitor and controls the controllable elements of a fluid system is utilized to monitor a fluid system for error conditions, to optimize operations and to diagnose the fluid system. By following a testing protocol that selectively enables parts of the system, the control means narrows the list of possible failing components. Comparing the measured pressure against normal pressures allows the device to identify error conditions. Determining the volume of fluid being transported and controlling the duration of the flow optimizes operation of the fluid system. | 10-02-2008 |
| 20090211978 | Passive column pre-heater with sample band spreading reduction feature - Disclosed is a chromatographic system and method which includes a passive pre-heater assembly. In the inventive system and method a fluid mixture is supplied from an injector to the pre-heater assembly and then to a chromatographic column having an active heating source. The pre-heater assembly includes a convoluted tube with first and second ends and a fluid passage extending centrally therebetween, first and second end fittings attached respectively to the first and second ends of the convoluted tube, and a thermally conductive film attached to an outer surface of the convoluted tube. The first end fitting is adapted for fluidly connecting the first end of the convoluted tube to the injector and the second end fitting is adapted for fluidly connecting the second end of the convoluted tube to the chromatographic column. The thermally conductive film conveys heat from an active heating source of a chromatographic column to the convoluted tube when the pre-heater assembly is positioned adjacent to the active heating source. The central fluid passage in the convoluted tube has a series of bends which function to create a secondary fluid flow field that is substantially orthogonal to a primary flow field established when fluid is traversing the fluid passage in the tube. | 08-27-2009 |
Randy S. Beals, Troy, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20090196787 | MAGNESIUM ALLOY - An improved, castable, magnesium-based alloy having good creep resistance, good corrosion resistance, with improved tensile strength and elongation; methods for preparing the alloys; methods for preparing articles from the alloys; and articles, machines, and other devices comprising the same. | 08-06-2009 |
Todd Beals, Westfield, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20110164066 | ELECTRONIC READING DEVICE - An electronic reading device provides automatic adjustment of image display and key functionality. An actuator and a plurality of keys symmetrically control the electronic reading device. A built-in motion detection mechanism detects changes in the orientation of the electronic reading device. The content of the display and the functionality of the actuator and plurality of keys is automatically adjusted based on the orientation of the device such that the actuator and the plurality of keys perform identical functions in a current orientation as were performed in a previous orientation. | 07-07-2011 |